Palisade Bio PALI Insider Ownership

NASDAQ PALI

$1.43 +0.09 (+6.72%)

At close: Oct 20, 2026 · 4:00 PM EDT

Insider Holdings by Owner

7.27Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

1.85%

▲+0.187% pp QoQ

Shares Held by Insiders

3.91Mn

filed for Sep 2026

▲+11.28% QoQ

Shares Outstanding

211.38Mn

211,381,969 shares

Direct Holdings

3.82Mn

Indirect: 90.45K

Net Shares Traded (QoQ)

+396.08K

net buying in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past year, PALI insiders bought $296,738 of stock (155K shares) and sold $420,178 (204.56K shares) on the open market.

By number of insiders, Palisade Bio saw 2 insiders buy and 2 insiders sell on the open market over the past 12 months.
Among PALI's insiders, Robert Baltera Jr. (Director) was the top open-market buyer in the past 12 months, with $250,182 of stock purchased (125K shares) and the latest purchase on July 9, 2026.
On the selling side, John David Finley (CEO, CFO) was the top open-market seller of Palisade Bio over the past 12 months, with $310,161 sold (150.69K shares) and the latest sale on July 7, 2026.
Donald Allen Williams (Director) made the most recent open-market trade by an insider of Palisade Bio, a purchase of 10K shares for $14,600 on October 2, 2026.
Outside the open market, Palisade Bio insiders received 2.43Mn shares in stock awards, acquired 6.42Mn shares through option exercises and conversions, gave up 2.44Mn shares to cover taxes or exercise prices and gave away 88.4K shares as gifts over the past 12 months.
Business Quant data shows Palisade Bio insiders holding 7.33Mn shares in total in their latest Form 4 filings, up 108.79% from 3.51Mn shares at the end of Q2 2026.
Direct holdings account for 7.24Mn shares (98.77%) of PALI's insider total, and indirect holdings through trusts, partnerships and family members for 90.45K shares (1.23%).
Holdings in Palisade Bio stock are reported by 7 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Palisade Bio's top three insider holders by shares held are John David Finley (CEO CFO, 2.03Mn shares), Mitchell Lawrence Jones (Officer, 1.68Mn shares) and Donald Allen Williams (Director, 1.59Mn shares).
John David Finley holds 27.72% of the combined insider position in Palisade Bio.
Institutional holders reported 82.02% of Palisade Bio's outstanding shares for Q2 2026; insiders' latest Form 4 filings put their stake at about 3.47%, and other investors, including the public, hold the remaining 14.51%.
A total of 23 Form 4 filings with transactions in Palisade Bio stock were made over the past 12 months, by 7 insiders.
The insider holdings and trades above for Palisade Bio reflect Form 4 filings through October 7, 2026.

Form 4 Holdings

Insiders Holding PALI

Insiders 14

Shares held 7.27Mn

Of outstanding 3.44%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	John David Finley	Ceo Cfo	1,958,162	0	1,958,162	26.9%	07 Oct, 2026
2	Mitchell Lawrence Jones	Chief Medical Officer	1,687,609	0	1,687,609	23.2%	07 Oct, 2026
3	Donald Allen Williams	Director	1,591,022	2,000	1,593,022	21.9%	05 Oct, 2026
4	Binxian Wei	Director	614,210	0	614,210	8.5%	12 Jun, 2026
5	Emil Chuang	Director	612,500	0	612,500	8.4%	12 Jun, 2026
6	Robert Jr. Baltera	Director	461,904	0	461,904	6.4%	10 Jul, 2026
7	Jordan Michael Zwick	Director	336,904	0	336,904	4.6%	12 Jun, 2026
8	Cristina Csimma	Director	858	0	858	0.0%	13 Feb, 2024
9	Stephanie Diaz	Director	853	0	853	0.0%	13 Feb, 2024
10	Robert J. Trenschel	Director	728	0	728	0.0%	13 Feb, 2024
11	James R Neal	Director	728	0	728	0.0%	13 Feb, 2024
12	Thomas Hallam	Chief Executive Officer	100	0	100	0.0%	18 Aug, 2022
13	Robert Curtis Mcrae	Chief Operating Officer	42	0	42	0.0%	05 Apr, 2023
14	Michael John Dawson	Chief Medical Officer	20	0	20	0.0%	30 Mar, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

558 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
06 Oct, 2026	John David Finley	Ceo Cfo	Acquired M	3,227,384	—	—	3,356,672	Direct
06 Oct, 2026	Mitchell Lawrence Jones	Officer	Acquired M	2,620,850	—	—	2,714,859	Direct
06 Oct, 2026	Mitchell Lawrence Jones	Officer	Disposed F	1,031,102	$1.49	$1.54Mn	1,683,757	Direct
06 Oct, 2026	John David Finley	Ceo Cfo	Disposed F	1,411,982	$1.49	$2.10Mn	1,944,690	Direct
06 Oct, 2026	Mitchell Lawrence Jones	Officer	Disposed M	2,555,266	$0.00	$0	5,110,534	Direct
06 Oct, 2026	John David Finley	Ceo Cfo	Disposed M	3,059,800	$0.00	$0	6,119,600	Direct
06 Oct, 2026	Mitchell Lawrence Jones	Officer	Disposed M	65,584	$0.00	$0	590,249	Direct
06 Oct, 2026	John David Finley	Ceo Cfo	Disposed M	167,584	$0.00	$0	1,508,249	Direct
01 Oct, 2026	Donald Allen Williams	Director	Acquired P	10,000	$1.42	$14.20K	1,580,294	Direct
02 Oct, 2026	Donald Allen Williams	Director	Acquired P	10,000	$1.46	$14.60K	1,590,294	Direct
19 Aug, 2026	John David Finley	Ceo, Cfo	Disposed G	88,400	$0.00	$0	129,288	Direct
19 Aug, 2026	John David Finley	Ceo, Cfo	Acquired G	88,400	$0.00	$0	88,451	Indirect
08 Jul, 2026	Robert Jr. Baltera	Director	Acquired P	20,000	$1.99	$39.80K	436,904	Direct
09 Jul, 2026	Robert Jr. Baltera	Director	Acquired P	25,000	$1.96	$48.90K	461,904	Direct
06 Jul, 2026	Robert Jr. Baltera	Director	Acquired P	20,000	$2.05	$41.04K	386,904	Direct
06 Jul, 2026	Mitchell Lawrence Jones	Chief Medical Officer	Acquired M	131,167	—	—	145,889	Direct
06 Jul, 2026	John David Finley	Ceo, Cfo	Acquired M	335,167	—	—	364,353	Direct
07 Jul, 2026	Mitchell Lawrence Jones	Chief Medical Officer	Disposed S	51,880	$2.05	$106.54K	94,009	Direct
07 Jul, 2026	Robert Jr. Baltera	Director	Acquired P	30,000	$2.03	$61.04K	416,904	Direct
07 Jul, 2026	John David Finley	Ceo, Cfo	Disposed S	146,798	$2.07	$303.34K	217,555	Direct

Showing 1 to 20 of 558 transactions